2021Zhongguo yixue lunlixueRequires access

The Common Problems and Countermeasures in the Process of Informed Consent of Drug Clinical Trials

Xie Jiangchuan, Wei Guo, Xie Linli, LI Ming-hong, Pan Xinmei, Cao Li-ya, Chen Yong-chuan

Open publisher page 0 citations

Abstract

Drug clinical trial is an important link to determine whether a new drug is safe and effective.Informed consent is an important document to protect the rights and interests of subjects in clinical trial.Based on its own work and combined with clinical trials projects,this paper discussed the problems existing in the signing of informed consent and analyzed the problems existing in the informed consent form and the problems that bidders,researchers,ethics committee and subjects should pay attention to when signing the informed consent form.To standardize and improve the problems of informed consent signing in order to contribute to the development of clinical trials.

About this research paper

What this paper is about

Drug clinical trial is an important link to determine whether a new drug is safe and effective.Informed consent is an important document to protect the rights and interests of subjects in clinical trial.Based on its own work and combined with clinical trials projects,this paper discussed the problems existing in the signing of informed consent and analyzed the problems existing in the informed consent form and the problems that bidders,researchers,ethics committee and subjects should pay attention to when signing the informed consent form.To standardize and improve the problems of informed consent signing in order to contribute to the development of clinical trials.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Drug clinical trial is an important link to determine whether a new drug is safe and effective.Informed consent is an important document to protect the rights and interests of subjects in clinical trial.Based on its own work and combined with clinical trials projects,this paper discussed the problems existing in the signing of informed consent and analyzed the problems existing in the informed consent form and the problems that bidders,researchers,ethics committee and subjects should pay attention to when signing the informed consent form.To standardize and improve the problems of informed consent signing in order to contribute to the development of clinical trials.

Key concepts: Informed consent, Clinical trial, Clinical research, Drug trial, Ethics committee, Medicine, Alternative medicine, Family medicine

Related papers

Back to paper searchBrowse research topicsOriginal source
The Common Problems and Countermeasures in the Process of Informed Consent of Drug Clinical Trials — Research Paper | ScholarLens